Skip Prichard

JULY 22, 2019

Let us give you our definition of what it means to be a founder: Playing a central role in starting and managing an initiative that will have impact (preferably visible and large) on an organization or the broader world. What better way to signal that you have leadership capabilities? ” Management Science 56.2

Innovation 80

Innovation Social Capital Reputation How To 80

The Idolbuster

JANUARY 15, 2013

I heard a cautionary tale from “George” the former VP of marketing at a mid-sized biotechnology company about how a bogus forecast helped propagate a disaster. Bad management? Research created an elaborate robotic system to streamline the user experience for one of the flagship product lines. Sounds like it.

Biotechnology 41

Biotechnology Groupthink CFO Stress 41

Harvard Business Review

APRIL 8, 2014

For example, if you are a biotechnology fund manager who wants to communicate the importance of investing in biotechnology, you may think that your value is in your recent success in investing for shareholders, but if you are a reasonable person, you will likely also have doubts about this.

Biotechnology 8

Biotechnology Audience Information Succession 8

Harvard Business Review

MAY 28, 2013

Not innovation, risk management, technology, debt, or the regulatory environment. Corporate directors identified talent management as their single greatest strategic challenge. We know that organizations commit enormous resources and effort to talent management, so why aren''t they doing a better job? Not competitive threats.

Talent Management 8

Talent Management Company Telecommunications Management 8

Harvard Business Review

MAY 1, 2014

I learned this while leading a turnaround of NPS Pharmaceuticals , a biotechnology company that now specializes in creating treatments for rare diseases. My senior executives and I made our values the language of leadership. Even individuals on NPS’s leadership team who didn’t embrace our values had to go.

Company 9

Company Pharmaceuticals Biotechnology Short-term 9

Harvard Business Review

MARCH 1, 2011

Editor's note: This post is part of a three-week series examining innovation in health care, published in partnership with the Advanced Leadership Initiative at Harvard University. And biotechnology and medical devices are among the leading areas for venture capital funding. Here, then, is the conundrum.

Health Care 15

Health Care Biotechnology Mayo Pharmaceuticals 15

Harvard Business Review

JUNE 3, 2013

Where was its leadership bench? What kind of signal did this choice send to P&G''s top managers? Is the problem that P&G produces outstanding specialists in marketing but not general managers who can run the business? We now see they are also struggling to do a good job managing their own talent responsibilities.

Succession 8

Succession Telecommunications Biotechnology Real Estate 8

Harvard Business Review

MAY 7, 2018

Only then would he be able to get a seat at the table, and even take over leadership of the meetings. She was on the legal compliance team at a fast-growing biotechnology company. In an effort to not step on toes, he had been deferring to his boss on the restructuring — but his passive approach was undermining him.

Restructuring 12

Restructuring How To Compliance Biotechnology 12

Harvard Business Review

MARCH 2, 2012

Here at Harvard Business School, Dean Nitin Nohria has revamped HBS's MBA curriculum to emphasize practical leadership and global experiences. It started 30 years ago with the progressive and unusual step (for that time) of shifting from local nationals as country managers to global leaders from other countries.

Competitive Advantage 13

Competitive Advantage Globalization Development Intellectual Capital 13

Harvard Business Review

DECEMBER 30, 2011

Organizations invest billions annually on a success curriculum known as "leadership development," which ends up leaving so much on the table. In other words, what if cultivating a successful inner life was front and center on the leadership agenda? The data-obsessed Pierce commissioned a third path impact report on PEP.

Development 17

Development Biotechnology CIO Short-term 17

Harvard Business Review

MARCH 30, 2017

Throughout this period, we have run a strategic execution exercise with executive groups focused on managing new, uncertain, and complex situations. With an average group size of 16, comprising senior executives, MBA students, general managers, scientists, teachers, and teenagers, our observations have been consistent.

Diversity 8

Diversity Team Biotechnology Execution 8

Harvard Business Review

AUGUST 23, 2016

Our limited sample suggests that both groups agree that board leadership should serve as champions of board diversity, but they differ on the policies they advocate to increase board diversity. Meanwhile, Democrats place greater importance on technology expertise and risk management.

Politics 8

Politics Committee Telecommunications Diversity 8

Tanveer Naseer

OCTOBER 20, 2015

Granted, this might seem like an obvious answer from someone who regularly writes and speaks about leadership. ” Listening to Qahtani’s words, I was reminded of two leaders and how their words served to shape how others viewed and responded to their leadership.

Power 100

Power Long-term Uncertainty Biotechnology 100

Harvard Business Review

OCTOBER 22, 2013

This industry is fueled by advances in chemistry and biotechnology that allow the use of pharmacological and cosmetic therapies in areas where, earlier, surgical intervention was needed. Convergence is not simply about combining ideas and technology; it is a primary leadership competency that allows organizations to design the right future.

Skills 8

Skills Power Six Sigma Disruptive Innovation 8

Harvard Business Review

APRIL 19, 2016

In virtually every advanced field, whether it’s information technology, biotechnology, agriculture, or renewable energy, America holds a leading position. Those factors do play important roles, but the most important thing driving America’s success has been its unparalleled scientific leadership. vincent tsui FOR HBR.

Innovation 8

Innovation Company Competitive Advantage Venture Funding 8

Harvard Business Review

JUNE 12, 2012

trillion in government support for seven "strategic emerging industries," including alternative energy, biotechnology, next-gen IT, high-end manufacturing equipment, and advanced materials. A decade from now we may look back at China's 12th Five-Year Plan as the seminal document of the early 21st century. It pledges $1.5

First-mover Advantage 9

First-mover Advantage GDP Technology Biotechnology 9

Harvard Business Review

FEBRUARY 3, 2015

When it comes to stepping up to leadership, your network is a tool for identifying new strategic opportunities and attracting the best people to them. This article will show you how to reinvent your network, by managing these three critical dimensions. Give you a sounding board to flesh out your ideas. The list goes on.

How To 8

How To Diversity Letter Learning-by-Doing 8

Harvard Business Review

JULY 22, 2015

” Hanguk was a large, fast-growing company with diversified interests spanning electronics, biotechnology, shipping, construction, and chemicals. Hanguk’s leadership would be watching the project closely, because expansion to the Arab world was one of its top strategic objectives. . “They want you for the Seoul job.

Case Study 8

Case Study Career Biotechnology Course 8